When H358 sgRB1#4tramR is grown without trametinib, cells develop vacuoles, similar to the phenotype we have previously reported that coincides with hyperactive MAPK signaling in KRAS mutant lung cancer cells33 (Fig. 2d). Here, KRAS is linked to lung cancer.